Cortical Contributions to FFR: Post-Op Outcomes

January 13, 2026 updated by: Taylor Abel, University of Pittsburgh

Cortical Contributions to Frequency-Following Response Generation and Modulation; Post-Operative Outcomes

The purpose of this study is to better understand cortical contributions of the human temporal lobe to the frequency-following response. Frequency-following responses (FFR) are electrophysiological recordings that reflect phase-locked activity of neural ensembles in the auditory pathway and are used as an indicator of the integrity of supra-threshold speech processing. FFR was first studied in subcortical areas, but recent consensus in the literature supports the notion that it is an integrated response between subcortical and cortical neural populations. The proposed study aims to deconstruct the role of the cortex in generating and modulating the FFR. The research team will build a novel computational model of FFR mechanisms and use EEG recordings from participants who have undergone resection of lesions in Heschl's gyrus to validate model predictions.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

The purpose of this study is to better understand the cortical contribution of the human temporal lobe to the generation and modulation of frequency-following responses (FFR).

The specific aims of this study is as follows:

  1. To build a novel computational model of cortical feedforward mechanisms involved in FFRs.
  2. To test model predictions of cortical removal in human participants who have undergone surgical resection of Heschl's gyrus lesions.

The hypothesis to be tested for the previously listed purposes and aims are as follows:

1. When cortical areas involved in generating and modulating the FFR, in this case Heschl's gyrus, are removed or inactivated, the FFR response will be attenuated.

The frequency-following response has been used extensively in auditory processing literature as a minimally invasive method of recording the integrity of supra-threshold speech processing. It was once considered to be reflective of only subcortical activity in structures like the brainstem, however a recent consensus has been reached in research on the topic that supports the notion of cortical neural population involvement in FFR as well.

The pilot study conducted under the initial parent grant for this study (Online Modulation of Auditory Brainstem Responses to Speech) proposed that subcortical auditory processing is not a hard-wired mechanism in the human brain but is rather continuously fine-tuned to stimuli by top-down expectations. This study further demonstrated that stimulus predictability, attention, and category-relevance have a robust effect on response fidelity and can modulate the FFR. The current study proposes to study the same effects and response patterns in cortical structures. Limited studies to date have investigated the effect of auditory cortex lesions on the FFR and existing studies did not account for the variables investigated in this study that are proposed to have a significant effect on modulation of FFRs.

Even though FFR is widely accepted as a metric for measuring the integrity of speech encoding, there remains a poor understanding of the neural generators of this response. A few studies to date have already identified abnormal or dysfunctional FFR in certain clinical populations like ADHD and autism spectrum disorders. The proposed study additionally seeks to identify the potential translational utility of FFR as a biomarker for clinical conditions.

This study is innovative as data from this study will allow researchers to build a novel computational model of cortical feedforward and feedback mechanisms, which will be tested in patient participants who have undergone surgical resection of Heschl's gyrus lesions.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15224
        • UPMC Children's Hospital of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Individuals 13-25 years old
  • Undergoing medically necessary surgical resection of Heschl's gyrus lesion
  • Monolingual English speakers
  • Receptive and expressive language within normal limits
  • Normal or corrected-to-normal visual acuity
  • Normal hearing acuity in each ear (as determined during an audiometric assessment)
  • Nonverbal IQ within normal limits
  • No history of autism spectrum disorder or attention-deficit hyperactivity disorder

Exclusion Criteria:

  • Significant medical or neuropsychological impairment that would result in the patient being unable to participate in study activities
  • History of autism or ADHD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neurosurgical Patients
Patient participants with previously excised tissue within Heschl's gyrus (as dictated by clinical care)
Participants will listen to repetitive speech sound stimuli, presented through headphones, which will induce a neural response (frequency-following response) to be measured via electroencephalography and pupillometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pitch Decoding Accuracy
Time Frame: During sEEG-EEG recording sessions, up to 3 hours total
Pitch decoding accuracy will be measured as a stimulus-to-response correlation between stimulus pitch (in Hz) and scalp-recorded frequency-following responses (FFR). Hidden Markov models (HMMs) will be used to decode stimulus identity information from recorded FFRs.
During sEEG-EEG recording sessions, up to 3 hours total
Frequency-Following Response Magnitude
Time Frame: During sEEG-EEG recording sessions, up to 3 hours total
The frequency-following response magnitude will be measured by analyzing the time-domain averaged spectral peak of scalp-recorded FFRs.
During sEEG-EEG recording sessions, up to 3 hours total
Cortical Phase-Locking Limits of Frequency-Following Response
Time Frame: During sEEG-EEG recording sessions, up to 3 hours total
Phase-locking limits of FFRs will be measured by comparing phase coherence of stimulus waveforms and scalp-recorded FFRs. The phase-locking limit will be determined as a function of dependence on stimulus frequency.
During sEEG-EEG recording sessions, up to 3 hours total
Predictability Effects of Cortical Resection on Pitch Decoding Accuracy
Time Frame: During follow-up research sessions, at least 6-months post-sEEG
The predictability effects of cortical resection on pitch decoding accuracy will be measured via comparison of decoding accuracies obtained in Outcome 1 and values predicted by a previously created computational model of frequency-following response constrained by data from neurotypical participants.
During follow-up research sessions, at least 6-months post-sEEG
Predictability Effects of Cortical Resection on Frequency-Following Response Magnitude
Time Frame: During follow-up research sessions, at least 6-months post-sEEG
The predictability effects of cortical resection on frequency-following response magnitude will be measured via comparison of response magnitude measurements obtained in Outcome 3 and values predicted by a previously created computational model of frequency-following response constrained by data from neurotypical participants.
During follow-up research sessions, at least 6-months post-sEEG
Predictability Effects of Cortical Resection on Phase-Locking Limits of Frequency-Following Response
Time Frame: During follow-up research sessions, at least 6-months post-sEEG
The predictability effects of cortical resection on phase-locking limits of the frequency-following response will be measured via comparison of phase-locking limits obtained in Outcome 3 and values predicted by a previously created computational model of frequency-following response constrained by data from neurotypical participants.
During follow-up research sessions, at least 6-months post-sEEG

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Taylor Abel, MD, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2023

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2030

Study Registration Dates

First Submitted

January 12, 2022

First Submitted That Met QC Criteria

January 27, 2022

First Posted (Actual)

January 28, 2022

Study Record Updates

Last Update Posted (Actual)

January 15, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY21100033
  • R01DC013315 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The individual deidentified participant data intended to be shared include the individual participant data that underlie the results to be reported in published articles after deidentification.

Other documents that will be available include the study protocol, statistical analysis plan, and analytic code.

Data will be available as soon as possible following publication, but no later than one year upon completion. There is no end date.

IPD will be made available for any purpose via open access.

IPD Sharing Time Frame

Data will be made available as soon as possible, but no later than one year upon completion of the study.

IPD Sharing Access Criteria

Our data will be made publicly available online as soon as possible. Data will be easily and widely accessible.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Language

Clinical Trials on Speech sound stimulation

Subscribe